Cybin Therapeutics, kambani yakazvimiririra yekurapa bioscience iri pachinangwa chekutsvaga nekugadzira psilocybin yakabatsira marapirwo maprotocol, yakapa rezinesi PEX010 (25 mg) kubva kuFilament kuti ishandiswe mukuedzwa. Muedzo unotarisirwa kutanga muQ3'22 uye uchasanganisira vanhu vane dambudziko guru rekuora mwoyo vari kusarudzwa serotonin reuptake inhibitor (SSRI) therapy, inowanzoshandiswa kurapa kuora mwoyo, pamwe chete neavo vari SSRI-vasingazivi.
"Kutenderwa kweHealth Canada humbowo hwechokwadi chekuedza uku pamwe nekugona kweFilament kugadzira nekupa marezenisi kune vanotora mishonga yemhando yemishonga," akadaro Filament Chief Executive Officer, Benjamin Lightburn. "Maitiro ekurapa kwepsilocybin muvarwere vanotora zvechinyakare SSRI antidepressant mishonga inongororo yakakosha uye tinofara kutora chikamu mukutsvaga kwakakosha uku."
"Vanhu vazhinji vekuCanada vanorwisa kuora mwoyo vanorapwa neSSRI, uye kusvika zvino, izvi zvave zvichireva kuti vabviswe mumiedzo yekiriniki yePsychedelic assisted psychotherapy (PAP)," akadaro Josh Taylor, Muvambi weCybin Therapeutics. "Kana zvichigona kuratidzwa kuti PAP inogona kupihwa zvakachengetedzeka uye zvinobudirira kuvarwere vari paSSRIs, vazhinji vanomira kuti vabatsirwe. Isu tinonzwa uyu mukana wakatanhamara wekuratidza Hutano Canada kuti Cybin Therapeutics inogona kuvandudza mhedzisiro yevarwere nechikwata chedu uye yakagadzira mapuroteni. "
Filament yakapawo rezinesi PEX010 (25 mg) kuCT yekuwedzera kwechikamu chechipiri chekiriniki miedzo, iyo inotarisirwa kutanga muchikamu chechina che2. Miedzo yose ichatungamirirwa naDkt Reg Peters naDave Phillips.
